MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) said it will release financial and operating results for the fourth quarter of 2025 before markets open Tuesday, March 17.
The company said it will host a conference call at 8:30 a.m. Eastern Time the same day to review the results.
The call will be available through a live webcast at https://edge.media-server.com/mmc/p/t8xxgfnr. Participants may also register to listen by telephone through the company’s conference registration link.
Neuronetics develops and markets neurohealth therapies, including the NeuroStar Advanced Therapy System, which provides noninvasive treatment for certain mental health conditions.
The therapy is used to treat depressive episodes and reduce anxiety symptoms in adults with major depressive disorder who have not improved after antidepressant treatment.
The system is also cleared by the U.S. Food and Drug Administration as an adjunct treatment for adults with obsessive-compulsive disorder and for adolescents aged 15 to 21 with major depressive disorder.
In addition to selling NeuroStar systems and treatment sessions, the company operates Greenbrook treatment centers across the United States that provide NeuroStar therapy, SPRAVATO, and other treatments for mental health conditions.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.